129 related articles for article (PubMed ID: 21820709)
1. Recurrence patterns and surveillance for patients with early stage endometrial cancer.
Salani R; Nagel CI; Drennen E; Bristow RE
Gynecol Oncol; 2011 Nov; 123(2):205-7. PubMed ID: 21820709
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance.
Bristow RE; Purinton SC; Santillan A; Diaz-Montes TP; Gardner GJ; Giuntoli RL
Gynecol Oncol; 2006 Nov; 103(2):709-13. PubMed ID: 16797686
[TBL] [Abstract][Full Text] [Related]
3. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
4. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
Cooper AL; Dornfeld-Finke JM; Banks HW; Davey DD; Modesitt SC
Obstet Gynecol; 2006 Jan; 107(1):71-6. PubMed ID: 16394042
[TBL] [Abstract][Full Text] [Related]
5. Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study.
Cicinelli E; Tinelli R; Colafiglio G; Fortunato F; Fusco A; Mastrolia S; Fucci AR; Lepera A
Menopause; 2010; 17(3):511-5. PubMed ID: 20081548
[TBL] [Abstract][Full Text] [Related]
6. Glandular cells in vaginal cytology Papanicolaou tests in patients with hysterectomy for endometrial adenocarcinoma.
Steele E; Umar SA; Bomeisl P; Miedler J; Zanotti KM; Wasman JK; Hunt DC; Abdul-Karim FW
Diagn Cytopathol; 2012 Feb; 40(2):138-40. PubMed ID: 20891002
[TBL] [Abstract][Full Text] [Related]
7. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme.
Reddoch JM; Burke TW; Morris M; Tornos C; Levenback C; Gershenson DM
Gynecol Oncol; 1995 Nov; 59(2):221-5. PubMed ID: 7590477
[TBL] [Abstract][Full Text] [Related]
9. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis.
Zola P; Fuso L; Mazzola S; Piovano E; Perotto S; Gadducci A; Galletto L; Landoni F; Maggino T; Raspagliesi F; Sartori E; Scambia G
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S150-4. PubMed ID: 17868785
[TBL] [Abstract][Full Text] [Related]
10. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma.
Berchuck A; Anspach C; Evans AC; Soper JT; Rodriguez GC; Dodge R; Robboy S; Clarke-Pearson DL
Gynecol Oncol; 1995 Oct; 59(1):20-4. PubMed ID: 7557610
[TBL] [Abstract][Full Text] [Related]
11. Post treatment surveillance of type II endometrial cancer patients.
Zakhour M; Li AJ; Walsh CS; Cass I; Karlan BY; Rimel BJ
Gynecol Oncol; 2013 Dec; 131(3):609-12. PubMed ID: 24051222
[TBL] [Abstract][Full Text] [Related]
12. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence.
Rasool N; Fader AN; Seamon L; Neubauer NL; Shahin FA; Alexander HA; Moore K; Moxley K; Secord AA; Kunos C; Rose PG; O'Malley DM
Gynecol Oncol; 2010 Jan; 116(1):10-4. PubMed ID: 19875158
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.
McCloskey SA; Tchabo NE; Malhotra HK; Odunsi K; Rodabaugh K; Singhal P; Lele S; Jaggernauth W
Gynecol Oncol; 2010 Mar; 116(3):404-7. PubMed ID: 19944453
[TBL] [Abstract][Full Text] [Related]
14. Patterns and utility of routine surveillance in high grade endometrial cancer.
Hunn J; Tenney ME; Tergas AI; Bishop EA; Moore K; Watkin W; Kirschner C; Hurteau J; Rodriguez GC; Lengyel E; Lee NK; Yamada SD
Gynecol Oncol; 2015 Jun; 137(3):485-9. PubMed ID: 25838164
[TBL] [Abstract][Full Text] [Related]
15. Costs and benefits of routine follow-up after curative treatment for endometrial cancer.
Agboola OO; Grunfeld E; Coyle D; Perry GA
CMAJ; 1997 Oct; 157(7):879-86. PubMed ID: 9327795
[TBL] [Abstract][Full Text] [Related]
16. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
17. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients.
Sartori E; Pasinetti B; Carrara L; Gambino A; Odicino F; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S241-7. PubMed ID: 17826824
[TBL] [Abstract][Full Text] [Related]
18. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
19. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
[TBL] [Abstract][Full Text] [Related]
20. Predictors of recurrence in surgical stage II endometrial adenocarcinoma.
Feltmate CM; Duska LR; Chang Y; Flynn CE; Nikrui N; Kiggundu E; Goodman A; Fuller AF; McIntyre JF
Gynecol Oncol; 1999 Jun; 73(3):407-11. PubMed ID: 10366468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
